Antag Therapeutics
biopharmaceutical company developing new treatments for obesity
Copenhagen, Denmarkantagtherapeutics.com ↗
Total raised
€80M
€80,000,000
Funding rounds
1
Investors
7
distinct backers
Active since
2024-12
latest 2024-12
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood49
base rate 44% for Series A
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-12-04 | Series A | €80M | Dawn Biopharma,Export and Investment Fund of Denmark (EIFO),Longview Ventures,Novo Holdings,Pictet,SR One+1 more | View deal → |
Investors
7Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech
- Doctolib€734MFrance · E-commerce